1. Home
  2. PMVP vs GNTA Comparison

PMVP vs GNTA Comparison

Compare PMVP & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • GNTA
  • Stock Information
  • Founded
  • PMVP 2013
  • GNTA 2014
  • Country
  • PMVP United States
  • GNTA Italy
  • Employees
  • PMVP N/A
  • GNTA N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PMVP Health Care
  • GNTA Health Care
  • Exchange
  • PMVP Nasdaq
  • GNTA Nasdaq
  • Market Cap
  • PMVP 55.1M
  • GNTA 81.2M
  • IPO Year
  • PMVP 2020
  • GNTA 2021
  • Fundamental
  • Price
  • PMVP $1.06
  • GNTA $3.05
  • Analyst Decision
  • PMVP Strong Buy
  • GNTA Strong Buy
  • Analyst Count
  • PMVP 1
  • GNTA 1
  • Target Price
  • PMVP $5.00
  • GNTA $25.00
  • AVG Volume (30 Days)
  • PMVP 283.2K
  • GNTA 11.1K
  • Earning Date
  • PMVP 08-07-2025
  • GNTA 01-01-0001
  • Dividend Yield
  • PMVP N/A
  • GNTA N/A
  • EPS Growth
  • PMVP N/A
  • GNTA N/A
  • EPS
  • PMVP N/A
  • GNTA N/A
  • Revenue
  • PMVP N/A
  • GNTA N/A
  • Revenue This Year
  • PMVP N/A
  • GNTA N/A
  • Revenue Next Year
  • PMVP N/A
  • GNTA N/A
  • P/E Ratio
  • PMVP N/A
  • GNTA N/A
  • Revenue Growth
  • PMVP N/A
  • GNTA N/A
  • 52 Week Low
  • PMVP $0.81
  • GNTA $2.79
  • 52 Week High
  • PMVP $1.82
  • GNTA $7.28
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 52.88
  • GNTA 37.03
  • Support Level
  • PMVP $1.01
  • GNTA $2.90
  • Resistance Level
  • PMVP $1.12
  • GNTA $3.39
  • Average True Range (ATR)
  • PMVP 0.08
  • GNTA 0.15
  • MACD
  • PMVP -0.00
  • GNTA -0.04
  • Stochastic Oscillator
  • PMVP 23.26
  • GNTA 34.82

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: